Terbinafine Hydrochloride Tablet
Product Images NDC 69097-731

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Terbinafine Hydrochloride (NDC 69097-731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Feb4ee13 5f95 4a62 8395 55bad95c424b 01)

Image (Feb4ee13 5f95 4a62 8395 55bad95c424b 01)
Chemical structure of Terbinafine Hydrochloride, the active ingredient in TERBINAFINE HYDROCHLORIDE tablets 250 mg by Cipla USA Inc. The diagram shows the molecular arrangement including aromatic rings, carbon chains, and the hydrochloride group.*
FDA Label Image

Image (Feb4ee13 5f95 4a62 8395 55bad95c424b 02)

Image (Feb4ee13 5f95 4a62 8395 55bad95c424b 02)
Label for Terbinafine Tablets USP 250 mg, human prescription oral tablets by Cipla USA Inc. The label indicates 30 tablets per container, with storage instructions and manufacturing details from Cipla Ltd., Verna Goa, India. It includes a barcode, NDC 69097-731-02, and space for serial number, expiry, and lot overprinting.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.